Senior Director Neuroscience Discovery, Europe @ (April 2012 - December 2017)
Independent Consultant @ JAK consulting (January 2010 - April 2012)
Chairman @ NeuroSolutions Ltd (October 2011 - March 2012)
Chief Research and Development Officer @ Evotec AG (January 2005 - January 2010)
CEO @ Evotec Neurosciences (July 2002 - May 2005)
Head of CNS Research @ (January 1999 - December 2001)
Research Area Head for Neurodegenerative Diseases @ (January 1994 - January 1999)
John Kemp Education
University of Southampton
Ph.D (Neuroscience/Neuropharmacology)
1974-1977
University of Portsmouth
B.Sc. (Pharmacology)
1971-1974
John Kemp Skills
Drug Discovery
Drug Development
Clinical Development
Pharmacology
Neuroscience
Electrophysiology
R&D
In Vitro
Clinical Research
Infectious Diseases
Biotechnology
Biopharmaceuticals
Toxicology
Cell Culture
Lifesciences
Oncology
Pharmaceutical Industry
Medicinal Chemistry
Technology Transfer
Neurodegeneration
CRO
Strategy
Biochemistry
Translational Medicine
Biomarkers
Biomarker Discovery
Clinical Trials
GCP
In Vivo
Assay Development
Cell Biology
Cell
Immunology
Life Sciences
John Kemp Summary
John Kemp, based in Basel, BS, CH, is currently a Owner at JAK & Gill Consulting GmbH. John Kemp brings experience from previous roles at Hoba Therapeutics, AbbVie, Syndesi Therapeutics and The Janssen Pharmaceutical Companies of Johnson & Johnson. John Kemp holds a 1974 - 1977 Ph.D in Neuroscience/Neuropharmacology @ University of Southampton. With a robust skill set that includes Drug Discovery, Drug Development, Clinical Development, Pharmacology, Neuroscience and more. John Kemp has 1 emails on RocketReach.
Looking for a different John Kemp?
Find contact details for 700 million professionals.